Across Europe, the outlook for women diagnosed with early breast cancer is likely to be far better now than at the start of my career. Effective screening programmes mean women are being diagnosed earlier, and greatly improved surgical techniques have also made a significant impact. Post-surgery, the evolution of adjuvant therapy has meant that we now have an armoury of effective treatments to stop breast cancer returning, although debate continues on how these treatments should be used for maximum benefit.
Apoyando a los profesionales de la oncología a través de la educación
El contenido de este sitio está destinado solo a profesionales de la salud
